Cavazzoni named director of FDA’s Center for Drug Evaluation and Research; Researchers study if vaccinated people can transmit virus; Sage and Biogen announce promising results in trial for essential tremor.
Five things for pharma marketers to know: Monday, April 12, 2021
COVID-19 double mutant variant cases identified in California; Australia, Italy join U.K. in restricting AstraZeneca vaccine; former Eli Lilly COO joins Thirty Madison as president.
Coronavirus Briefing: Controlling the crowds, navigating the landscape, smoothing the way
Biden says all U.S. adults eligible for vaccine by April 19; FDA extends review of Pfizer skin drug; Novartis makes $1.3 billion deal with Artios for oncology drugs.
Federal retail pharmacy vax program continues to expand
U.S. administering an average of 3.1 million COVID-19 vaccine doses per day; FDA rejects Acadia application to expand use of anti-psychosis drug; Johnson & Johnson bets $780 million on flu antiviral conjugate therapies.
Loading...
Culture drives the company
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
Want to read more?
Please login or register first to view this content.
